Howard Capital Management Group’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$199K Hold
3,455
0.01% 137
2026
Q1
$210K Hold
3,455
0.01% 129
2025
Q4
$186K Sell
3,455
-5,281
-60% -$254K 0.01% 132
2025
Q3
$394K Buy
+8,736
New +$408K 0.02% 100
2025
Q2
Sell
-3,455
Closed -$211K 139
2025
Q1
$211K Hold
3,455
0.02% 116
2024
Q4
$195K Buy
+3,455
New +$193K 0.01% 123
2024
Q2
Sell
-3,475
Closed -$188K 127
2024
Q1
$188K Sell
3,475
-239
-6% -$12.2K 0.01% 117
2023
Q4
$191K Buy
3,714
+40
+1% +$2.1K 0.02% 103
2023
Q3
$213K Hold
3,674
0.02% 96
2023
Q2
$235K Hold
3,674
0.02% 93
2023
Q1
$255K Sell
3,674
-250
-6% -$17.6K 0.03% 90
2022
Q4
$282K Hold
3,924
0.03% 83
2022
Q3
$279K Hold
3,924
0.04% 79
2022
Q2
$302K Hold
3,924
0.04% 79
2022
Q1
$287K Hold
3,924
0.03% 87
2021
Q4
$245K Sell
3,924
-70
-2% -$4.11K 0.02% 100
2021
Q3
$236K Sell
3,994
-45
-1% -$2.96K 0.02% 96
2021
Q2
$270K Hold
4,039
0.03% 94
2021
Q1
$255K Buy
+4,039
New +$251K 0.03% 83

Other funds holding BMY

Howard Capital Management Group's BMY Position: Q2 2026 in Review

Howard Capital Management Group held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 3,455 shares worth $199K. The position accounts for 0.01% of the portfolio, ranked #137.

Howard Capital Management Group first reported a position in BMY in Q1 2021 and has held it in 19 quarters since. The position peaked at $394K in Q3 2025. 834 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Howard Capital Management Group held 3,455 shares of Bristol-Myers Squibb worth $199K as of Q2 2026.
  • Howard Capital Management Group left its Bristol-Myers Squibb share count unchanged in Q2 2026.
  • Bristol-Myers Squibb made up 0.01% of Howard Capital Management Group's portfolio in Q2 2026, its #137 holding.
  • Howard Capital Management Group first reported a position in Bristol-Myers Squibb in Q1 2021 and has held it in 19 quarters since.
  • Howard Capital Management Group's Bristol-Myers Squibb position peaked at $394K in Q3 2025.
  • 834 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Howard Capital Management Group's 13F filing for Q2 2026, filed 16 Jul 2026.